Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 0 | 353 | 0 | 0 | 0 |
| Gross Profit | N/A | 353 | N/A | N/A | N/A |
| Operating Expenses | 15,959 | 12,968 | 13,558 | 12,787 | 18,336 |
| Operating Income | -15,959 | -12,615 | -13,558 | -12,787 | -7,950 |
| Other Income | 1,198 | 1,273 | 1,216 | 835 | 427 |
| Pre-tax Income | -14,761 | -11,342 | -12,342 | -11,952 | -7,523 |
| Net Income Continuous | -14,761 | -11,342 | -12,342 | -11,952 | -7,523 |
| Minority Interests | -13 | 2 | 4 | -1 | -8 |
| Net Income | $-14,752 | $-11,340 | $-12,346 | $-11,951 | $-7,515 |
| EPS Basic Total Ops | -0.23 | -0.20 | -0.22 | -0.29 | -0.26 |
| EPS Basic Continuous Ops | -0.24 | -0.20 | -0.22 | -0.29 | -0.25 |
| EPS Diluted Total Ops | -0.23 | -0.20 | -0.22 | -0.29 | -0.26 |
| EPS Diluted Continuous Ops | -0.24 | -0.20 | -0.22 | -0.29 | -0.25 |
| EBITDA(a) | $-16,445 | $-12,599 | $-13,854 | $-12,451 | $-17,671 |